RILUTEK

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RILUTEK contains one active pharmaceutical ingredient (API):

1 Riluzole UNII 7LJ087RS6F - RILUZOLE

Riluzole is proposed to act by inhibiting glutamate processes. The mode of action is unclear. It is suggested that glutamate (the primary excitatory neurotransmitter in the central nervous system) plays a role for cell death in the ALS disease. Read about Riluzole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RILUTEK Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX02	Riluzole	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8664B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502811101116311
Country: CA	Health Products and Food Branch	Identifier(s): 02242763
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00426207, 00595855, 01607885, 07499770, 10276737, 10989986
Country: EE	Ravimiamet	Identifier(s): 1035289
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 96010001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 123992
Country: FR	Base de données publique des médicaments	Identifier(s): 66292199
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36847, 368734
Country: HK	Department of Health Drug Office	Identifier(s): 42525
Country: IE	Health Products Regulatory Authority	Identifier(s): 88150, 88734, 88891, 89013
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4299
Country: IT	Agenzia del Farmaco	Identifier(s): 032887010
Country: JP	医薬品医療機器総合機構	Identifier(s): 1190011F1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1014212
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 133M97
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 45225
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7595
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100083164
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66040001
Country: SG	Health Sciences Authority	Identifier(s): 09426P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809090361
Country: US	FDA, National Drug Code	Identifier(s): 70515-700
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/34/0229